On April 7 Exxon Mobil held informal talks of mergers and acquisitions with Pioneer Natural Resources, potentially kicking off a fresh wave of consolidation in the energy sector.
M&A activity slumped in 2022, but many industry experts expect a rebound in 2023 with Lucid Motors and other attractively valued companies
The biotechnology sector was one of the worst underperformers in 2021, but this niche of the financial markets could see a big rebound in 2022.
Long options strategies haven’t produced attractive win rates historically, but in merger or buyout situations, such positions can produce significant profits.
New offerings of Special Purpose Acquisition Companies (SPACs) were red-hot in 2020, outpacing even traditional initial public offerings (IPOs) for the first time in history. After a slow start to 2020, initial public offerings (IPOs) rebounded in strong fashion during the second half of the year. That wasn’t necessarily surprising because owners of private companies … Continued
Valuations in the biotechnology sector received a boost on Dec. 12 when AstraZeneca (AZN) announced it would pay a 45% premium for Alexion Pharmaceuticals (ALXN), a stock that had already rallied 47% since mid-March. On Dec. 11, the Food & Drug Administration (FDA) made history when it approved the first COVID-19 vaccine for use by … Continued
Merger and acquisition (M&A) activity shrunk during the first half of 2020 by roughly 50% as compared to last year, but since July, the pace has picked up considerably. The uptick in activity was punctuated by two recent mega-deals—the acquisition of Arm Limited by Nvidia (NVDA) and the acquisition of Immunomedics (IMMU) by Gilead (GILD)—together … Continued
Market participants who love to trade mergers and acquisitions, as well as other corporate actions, have had a cornucopia of opportunities to choose from in 2019. And the list of companies involved in M&A deals got a little longer last week, with LVMH (owner of Louis Vuitton) buying U.S.-based Tiffany (TIF), and Charles Schwab (SCHW) … Continued